Abstract

Classical aortic valve replacement is often fraught with negative outcomes for patients. When replacing the aortic valve with a mechanical valve prosthesis, the patient is associated for life with the use of indirect anticoagulants, which often leads to hemorrhagic and thrombotic complications. In the case of replacement of the aortic valve with a biological prosthesis, a fairly frequent complication is early calcification and, consequently, a high frequency of dysfunctions of the biological prosthesis. In addition, mechanical and biological prosthetics of heart valves are quite expensive, which creates a serious economic load on the healthcare institution. But in the last decade, the technique of neocuspidization of the aortic valve with autopericardial flaps has been introduced into wide cardiac surgical practice, which is a clear alternative to prosthetics of heart valves.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call